Phil Hamzik helps clients build and manage US and international patent portfolios in the areas of pharmaceuticals and biotechnology. He has secured comprehensive patent protection on behalf of clients, including patents to compound libraries, clinical stage candidates, formulations, combination therapies and synthetic methods. Phil has extensive knowledge and experience in the areas of medicinal chemistry and drug discovery, organic synthesis, polymer chemistry, polypeptide and oligonucleotide therapeutics, and more.
Phil works with a diverse range of clients, including small to large pharmaceutical and biotechnology companies, universities, and research institutes. In addition to patent application drafting and prosecution, he provides clients with strategic advice and assists with patentability, freedom-to-operate and due diligence work.
Prior to joining Wolf Greenfield, Phil obtained his PhD in Organic Chemistry from the Massachusetts Institute of Technology. His doctoral research focused on the development of new cycloaddition strategies for the synthesis of highly substituted nitrogen heterocycles. Phil completed his undergraduate studies at Northeastern University, where he obtained a BS in Chemistry and Philosophy.
Phil also brings industry experience to his practice, having worked for two leading pharmaceutical companies. As an intern at Merck Research Laboratories in Boston, Phil developed new synthetic methods for the preparation of important molecular scaffolds. At Novartis Institutes for BioMedical Research in Cambridge, he worked as a medicinal chemistry intern in the area of infectious diseases.